Table 1. Factors exhibiting clinical relevance.
Surgical treatment | Biopsy | |
---|---|---|
Age (mean) | ||
42.21 | 50.61 | |
p = 0.053 | ||
Tumor volume (mean) | ||
26.28 | 32.13 | |
p = 0.255 | ||
Ki-67 proportions (mean) | ||
18.95 | 28.35 | |
p = 0.007 | ||
Tumor components (n) | ||
Cystic | 0 | 1 |
Solid | 8 | 12 |
Solid & cystic | 11 | 10 |
p = 0.635 | ||
Ventricle wall enhancement (n) | ||
Yes | 0 | 16 |
No | 19 | 7 |
p = 2.01E-06 | ||
Multiple lesions (n) | ||
Yes | 0 | 7 |
No | 19 | 16 |
p = 0.011 | ||
Brainstem extension (n) | ||
Yes | 12 | 8 |
No | 7 | 15 |
p = 0.128 | ||
Tumor location (n) | ||
Anterior | 3 | 2 |
Lateral | 3 | 1 |
Lateral posterior inferior | 6 | 4 |
Medial | 3 | 4 |
Medial posterior inferior | 2 | 5 |
Posterosuperior | 2 | 7 |
p = 0.4 | ||
Motor symptoms (n) | ||
Yes | 16 | 23 |
No | 3 | 0 |
p = 0.084 | ||
Sensory symptoms (n) | ||
Yes | 6 | 8 |
No | 13 | 15 |
p = 1.0 | ||
Language symptoms (n) | ||
Yes | 1 | 3 |
No | 18 | 20 |
p = 0.614 | ||
Visual symptoms (n) | ||
Yes | 5 | 5 |
No | 14 | 18 |
p = 1.0 | ||
Cognitive symptoms (n) | ||
Yes | 10 | 16 |
No | 9 | 7 |
p = 0.421 | ||
MGMT status (n) | ||
Methylated | 10 | 7 |
Un-methylated | 9 | 16 |
p = 0.253 |
Mean values were analyzed using t-test and all other measures were analyzed using the chi-squared or Fisher’s exact tests. Bold indicates significant results(p-value<0.05). MGMT, O6-methylguanine- DNA methyltransferase